Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference
TAIPEI and SAN DIEGO, Dec. 23, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined...
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy
TAIPEI and SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant's biological...
Global AI and Semiconductor Leaders Converge at AISC 2025: Aitomatic Reveals Advances in Semiconductor Foundation Model SemiKong
HANOI, Vietnam, Jan. 23, 2025 /PRNewswire/ -- The Industrial AI Federation, Aitomatic, and the National Innovation Center of Vietnam announced today the AI-Semiconductor Conference (AISC) 2025. The conference will bring together over 1,000 global...
Kristine Tompkins and Lila Ibrahim offer compelling perspectives on CNN's Visionaries
HONG KONG, Dec. 12, 2024 /PRNewswire/ -- In the second episode of Visionaries, Bill Weir speaks with former Patagonia CEO Kristine Tompkins about her mission to channel company revenue towards environmental conservation. Meanwhile, Anna Stewart...